BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34832531)

  • 1. Fall of Community-Acquired Pneumonia in Children following COVID-19 Non-Pharmaceutical Interventions: A Time Series Analysis.
    Rybak A; Yang DD; Schrimpf C; Guedj R; Levy C; Cohen R; Gajdos V; Tort J; Skurnik D; Ouldali N; Angoulvant F
    Pathogens; 2021 Oct; 10(11):. PubMed ID: 34832531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Shift in Clinical Profile of Hospitalized Pneumonia in Children in the Non-pharmaceutical Interventions Period During the COVID-19 Pandemic: A Prospective Multicenter Study.
    Rybak A; Ouldali N; Angoulvant F; Minodier P; Biscardi S; Madhi F; Hau I; Santos A; Bouvy E; Dubos F; Martinot A; Dommergues MA; Gras-Le Guen C; Launay E; Levieux K; Zenkhri F; Craiu I; Lorrot M; Gillet Y; Mezgueldi E; Faye A; Béchet S; Varon E; Cohen R; Levy C
    Front Pediatr; 2022; 10():782894. PubMed ID: 35391746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Association of 13-Valent Pneumococcal Conjugate Vaccine Implementation With Rates of Community-Acquired Pneumonia in Children.
    Ouldali N; Levy C; Minodier P; Morin L; Biscardi S; Aurel M; Dubos F; Dommergues MA; Mezgueldi E; Levieux K; Madhi F; Hees L; Craiu I; Gras Le Guen C; Launay E; Zenkhri F; Lorrot M; Gillet Y; Béchet S; Hau I; Martinot A; Varon E; Angoulvant F; Cohen R
    JAMA Pediatr; 2019 Apr; 173(4):362-370. PubMed ID: 30715140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mortality and years of life lost for community-acquired pneumonia before and during COVID-19 pandemic in China.
    Fan G; Zhou Y; Zhou F; Yu Z; Gu X; Zhang X; Liu Z; Zhou M; Cao B
    Lancet Reg Health West Pac; 2024 Jan; 42():100968. PubMed ID: 38022712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of COVID-19 non-pharmaceutical interventions on HIV care continuum in China: An interrupted time series analysis.
    Wu X; Wu G; Ma Y; Huang X; Yang Y; Cai Y; Luo G; Ma P; Qiao Y; Chen Y; Lin YF; Gao Y; Zhan Y; Song W; Wang Y; Wang R; Yang X; Sun L; Wei H; Li Q; Xin X; Wang L; Wang X; Xie R; Yang L; Meng X; Zhao J; Li L; Zhang T; Xu J; Fu G; Zou H
    Lancet Reg Health West Pac; 2022 Dec; 29():100569. PubMed ID: 35966023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children.
    Angoulvant F; Levy C; Grimprel E; Varon E; Lorrot M; Biscardi S; Minodier P; Dommergues MA; Hees L; Gillet Y; Craiu I; Zenkhri F; Dubos F; Guen CG; Launay E; Martinot A; Cohen R
    Clin Infect Dis; 2014 Apr; 58(7):918-24. PubMed ID: 24532543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric Non-COVID-19 Community-Acquired Pneumonia in COVID-19 Pandemic.
    Huang C
    Int J Gen Med; 2021; 14():7165-7171. PubMed ID: 34737611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respective roles of non-pharmaceutical interventions in bronchiolitis outbreaks: an interrupted time-series analysis based on a multinational surveillance system.
    Lenglart L; Ouldali N; Honeyford K; Bognar Z; Bressan S; Buonsenso D; Da Dalt L; De T; Farrugia R; Maconochie IK; Moll HA; Oostenbrink R; Parri N; Roland D; Rose K; Akyüz Özkan E; Angoulvant F; Aupiais C; Barber C; Barrett M; Basmaci R; Castanhinha S; Chiaretti A; Durnin S; Fitzpatrick P; Fodor L; Gomez B; Greber-Platzer S; Guedj R; Hey F; Jankauskaite L; Kohlfuerst D; Mascarenhas I; Musolino AM; Pučuka Z; Reis S; Rybak A; Salamon P; Schaffert M; Shahar-Nissan K; Supino MC; Teksam O; Turan C; Velasco R; Nijman RG; Titomanlio L;
    Eur Respir J; 2023 Feb; 61(2):. PubMed ID: 36356971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hospitalization of mild cases of community-acquired pneumonia decreased more than severe cases during the COVID-19 pandemic.
    Nagano H; Takada D; Shin JH; Morishita T; Kunisawa S; Imanaka Y
    Int J Infect Dis; 2021 May; 106():323-328. PubMed ID: 33794382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of COVID-19 on hospital visits in Ningbo, China: an interrupted time-series analysis.
    Yang ZM; Wu MY; Lu JM; Li TZ; Shen P; Tang ML; Jin MJ; Lin HB; Shui LM; Chen K; Wang JB
    Int J Qual Health Care; 2021 May; 33(2):. PubMed ID: 33909042
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of COVID-19-targeted nonpharmaceutical interventions on children's respiratory admissions in China: a national multicenter time series study.
    Wang X; Xu H; Chu P; Zeng Y; Tian J; Song F; Guo Y; Xu X; Ni X; Feng G
    Int J Infect Dis; 2022 Nov; 124():174-180. PubMed ID: 36241166
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emergency department management of childhood pneumonia in the United States prior to publication of national guidelines.
    Neuman MI; Shah SS; Shapiro DJ; Hersh AL
    Acad Emerg Med; 2013 Mar; 20(3):240-6. PubMed ID: 23517255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The COVID-19 Pandemic and the Incidence of the Non-COVID-19 Pneumonia in Adults.
    Huang C
    Front Med (Lausanne); 2021; 8():737999. PubMed ID: 34859006
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of pneumococcal conjugate vaccine in children morbidity and mortality in Peru: Time series analyses.
    Suarez V; Michel F; Toscano CM; Bierrenbach AL; Gonzales M; Alencar AP; Ruiz Matus C; Andrus JK; de Oliveira LH
    Vaccine; 2016 Sep; 34(39):4738-4743. PubMed ID: 27521230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of early mitigation measures against COVID-19 in Puerto Rico: March 15-May 15, 2020.
    Valencia M; Becerra JE; Reyes JC; Castro KG
    PLoS One; 2020; 15(10):e0240013. PubMed ID: 33052958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effectiveness of the non-pharmaceutical public health interventions against COVID-19; a protocol of a systematic review and realist review.
    Iezadi S; Azami-Aghdash S; Ghiasi A; Rezapour A; Pourasghari H; Pashazadeh F; Gholipour K
    PLoS One; 2020; 15(9):e0239554. PubMed ID: 32991604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mental Health-Related Emergency Department Visits Among Children Aged <18 Years During the COVID-19 Pandemic - United States, January 1-October 17, 2020.
    Leeb RT; Bitsko RH; Radhakrishnan L; Martinez P; Njai R; Holland KM
    MMWR Morb Mortal Wkly Rep; 2020 Nov; 69(45):1675-1680. PubMed ID: 33180751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of COVID-19 on routine malaria indicators in Uganda: An interrupted time series analysis.
    Namuganga JF; Briggs J; Roh ME; Okiring J; Kisambira Y; Sserwanga A; Kapisi JA; Arinaitwe E; Ebong C; Ssewanyana I; Greenhouse B; Maiteki-Ssebuguzi C; Kamya MR; Staedke SG; Dorsey G; Nankabirwa JI
    Res Sq; 2021 Aug; ():. PubMed ID: 34426808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Viral community acquired pneumonia at the emergency department: Report from the pre COVID-19 age.
    Spagnolello O; Pierangeli A; Cedrone MC; Di Biagio V; Gentile M; Leonardi A; Valeriano C; Innocenti GP; Santinelli L; Borrazzo C; Russo A; Oliveto G; Viscido A; Ciccozzi M; Bertazzoni G; d'Ettorre G; Ceccarelli G
    J Med Virol; 2021 Jul; 93(7):4399-4404. PubMed ID: 33783850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of PCV13 on community-acquired pneumonia by C-reactive protein and procalcitonin levels in children.
    Levy C; Biscardi S; Dommergues MA; Dubos F; Hees L; Levieux K; Aurel M; Minodier P; Zenkhri F; Cohen R;
    Vaccine; 2017 Sep; 35(37):5058-5064. PubMed ID: 28778617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.